3.77
-0.31 (-7.60%)
| Penutupan Terdahulu | 4.08 |
| Buka | 3.97 |
| Jumlah Dagangan | 1,362,180 |
| Purata Dagangan (3B) | 1,707,962 |
| Modal Pasaran | 269,237,184 |
| Harga / Jualan (P/S) | 1.69 |
| Harga / Buku (P/B) | 7.07 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 May 2025 - 9 May 2025 |
| Margin Keuntungan | -54.23% |
| Margin Operasi (TTM) | -34.45% |
| EPS Cair (TTM) | -1.32 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 83.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 208.79% |
| Nisbah Semasa (MRQ) | 2.44 |
| Aliran Tunai Operasi (OCF TTM) | -35.98 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -21.69 M |
| Pulangan Atas Aset (ROA TTM) | -19.38% |
| Pulangan Atas Ekuiti (ROE TTM) | -144.50% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Menurun | Menurun |
| Diagnostics & Research (Global) | Menurun | Menurun | |
| Stok | Neuronetics, Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.88 |
|
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 9.17% |
| % Dimiliki oleh Institusi | 62.81% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Nkcfo Llc | 31 Mar 2025 | 125,000 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 10 Jun 2025 | Pengumuman | Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program |
| 02 Jun 2025 | Pengumuman | Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes |
| 14 May 2025 | Pengumuman | Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month |
| 06 May 2025 | Pengumuman | Neuronetics Reports First Quarter 2025 Financial and Operating Results |
| 05 May 2025 | Pengumuman | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) |
| 22 Apr 2025 | Pengumuman | Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call |
| 31 Mar 2025 | Pengumuman | Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression |
| 27 Mar 2025 | Pengumuman | Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |